X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

EMBO REPORTS

期刊標題檢索 EMBO REP 最新評論: Returning to Zone One (2023-12-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[EMBO REPORTS]您好,您是該頁面的第 126745 位訪客。

期刊簡介
期刊名稱EMBO REPORTS EMBO REPORTS
LetPub Score
9.0
50 ratings
Rate

Reputation
10.0

Influence
8.2

Speed
9.4

期刊簡稱EMBO REP
ISSN1469-221X
E-ISSN1469-3178
h-index164
CiteScore
CiteScoreSJRSNIPCiteScore Rank
11.203.1931.286
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q132 / 347
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Biochemistry
Q145 / 438
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q161 / 410

自引率 (2023-2024)1.50%自引率趨勢
掲載範囲
EMBO reports publishes scientific research in all areas of molecular and cell biology, as well as scientific reviews and commentary from leading experts that explore science & society.

EMBO reports has a fair and transparent process (http://embor.embopress.org/about#Transparent_Process) to rapidly publish important science. Anonymous referee reports and editorial correspondence are published alongside manuscripts as Review Process Files in the Transparent Process section online.
官方網站http://embor.embopress.org/
在線稿件提交http://embor.msubmit.net/cgi-bin/main.plex
開放訪問No
出版商Wiley-Blackwell
主題領域生物
出版國/地區ENGLAND
發行頻率月刊
創刊年2000
每年文章數250每年文章數趨勢
黃金OA百分比54.55%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ142/313
CELL BIOLOGYSCIEQ143/205
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1469-221X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【EMBO REPORTS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1278794
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS570963
    JOURNAL OF BIOLOGICAL CHEMISTRY395994
    NUCLEIC ACIDS RESEARCH338136
    CELL298257
    FASEB JOURNAL267143
    International Journal of Biological Sciences236845
    PLANT SCIENCE228211
    Molecular Cancer212772
    ONCOGENE200853
  •  

    EMBO REPORTS EMBO REPORTS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [EMBO REPORTS] 的評論撰寫評論
作者: 四风丽苹


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-27 11:34:41 評論於
Returning to Zone One
(0) 讚! | 四风丽苹

作者: Alexander Browne


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-05 13:15:39 評論於
How long did it take for you to receive the successful submission email?
(0) 讚! | Alexander Browne

作者: 桃花高驰


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-02 16:35:43 評論於
Review Speed: 3.0 | Submission Acceptance Rate: 25.0
Experience Sharing: Lucky to have one article accepted. Although the Impact Factor is not high, the quality of the journal is very good and the review process is very strict
(0) 讚! | 桃花高驰

作者: 长安丝琦


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-18 12:34:33 評論於
The initial review process will take about 50 days, within two months
(0) 讚! | 长安丝琦

作者: Jackson S2023


領域: 生物学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-09-05 20:54:47 評論於
The authoritative journal in the field of molecular biology has strict review process. The review team consists of industry experts, and the review comments are very professional and of high quality. Articles with a high workload are worth a try
(60) 讚! | Jackson S2023

作者: 蒙德明知


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-18 19:47:22 評論於
Within one month
(0) 讚! | 蒙德明知

作者: 风见婉君


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-24 18:08:57 評論於
The first trial will be completed in about a month
(0) 讚! | 风见婉君

作者: 风见婉君


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-24 12:00:40 評論於
Fast delivery, within one week
(0) 讚! | 风见婉君

作者: 四风丽苹


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-21 23:25:23 評論於
Within a week
(0) 讚! | 四风丽苹

作者: 月河樱潼


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-21 08:42:14 評論於
Okay, thank you
(0) 讚! | 月河樱潼

作者: 月河樱潼


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-07 16:22:08 評論於
Recently, there are teachers who have submitted to this journal. How long does the initial review usually take?
(0) 讚! | 月河樱潼

作者: 蒙德明知


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-06 12:21:48 評論於
I really don't understand why this journal, which is quite good, has been categorized as level two
(0) 讚! | 蒙德明知

作者: keyanxiaolj


領域: 生物学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2022-12-26 09:59:42 評論於
Old magazines, the reputation is still good. The review process is also very rigorous, unlike some inferior journals. What is puzzling is that a small CDD edited by a Chinese expert has become a first-tier journal, while this one has been kicked out of the first-tier. I can't understand it.
(36) 讚! | keyanxiaolj

作者: 指挥棒


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-12-22 20:01:54 評論於
I don't know if the leaders of the country are aware of how excessively the Chinese Academy of Sciences uses the baton in its division. Supporting domestic journals is a good thing, but it shouldn't be done at the expense of pulling up seedlings to help them grow. It disregards the life and death of personnel without qualifications. This is also the way it is for the scientific research big shots. They randomly publish and it becomes a first-tier journal. Thumbs up!
(0) 讚! | 指挥棒

作者: 指挥棒


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-12-22 19:55:58 評論於
Typical of making a big deal out of trivial matters, replacing classic journals with domestic ones. But can the domestic journals be obtained by researchers with no qualifications? They are just taking advantage of leaders' lack of understanding in research and messing around, truly amazing!
(0) 讚! | 指挥棒

作者: 指挥棒


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-12-22 19:51:14 評論於
?, kick out of the first division, kick out of the top, IJMS and other water journals are all top, is this how you use a baton?
(32) 讚! | 指挥棒

作者: 方建


領域: 生物学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2022-12-22 09:22:12 評論於
Currently, there is a paper in the second round of review, which has been resubmitted to a different journal after being rejected by a top-tier journal. The first round of review provided more than 20 comments, which were exceptionally strict.

Does the classification system of the Chinese Academy of Sciences aim to eliminate good papers in favor of inferior ones?
(28) 讚! | 方建

作者: 四风丽苹


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-19 11:39:41 評論於
Research focus: Experience sharing of stem cells: Haha, everyone don't submit anymore, as the latest version of the Chinese Academy of Sciences partition in 2022, this journal has been removed from the first tier. The authority is powerful!
(0) 讚! | 四风丽苹

作者: 辉夜一莹


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-25 20:25:14 評論於
Review speed: 2.0 | Submission hit rate: 25.0 Emphasized research direction: Tumor sharing experience: EMBO reports The current editor-in-chief is Professor Bernd Pulverer, who previously served as the editor of Nature Cell Biology. The magazine tends to publish articles with conceptual advances, with an average time from submission to acceptance of around 8 months
(0) 讚! | 辉夜一莹

作者: slientwo


領域: 生物学
審稿時間: 6.0 month(s)
結果: 直接被接受


撰寫評論

2022-10-18 12:19:05 評論於
EMBO Publishing House, the second-in-command, was established in 2000. Cell reports, under the umbrella of CELL, should be imitating the publishing concept of this magazine, with an extremely similar style. However, EMBO reports are more rigorous. Everyone can try submitting their articles, and if you get accepted after external review, you will have a profound experience. It mainly accepts articles related to molecular biology. The magazine is very good, but there are very few Chinese submissions. It is mainly favored by some researchers from Chinese institutes.
(10) 讚! | slientwo

作者: 弘致小姐姐


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-25 23:31:01 評論於
Are you going back for rework? How long has the rework been going on? What is the status like?
(0) 讚! | 弘致小姐姐

作者: 平原如彤


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-04 11:15:46 評論於
How can I not receive the decision letter, the editor does not reply, what should I do
(0) 讚! | 平原如彤

作者: 墟散伟博


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-14 21:28:55 評論於
How long did it take for you to receive the email after May 11th?
(0) 讚! | 墟散伟博

作者: 火焰自明


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-07 19:13:47 評論於
How long does it take to revise and resubmit after a rejection? Was the initial review process positive?
(0) 讚! | 火焰自明

作者: 维尔娜菲茨杰拉德


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:20:28 評論於
Do not submit to newly established magazines with rapidly increasing impact factors; do not submit to journals with fewer published articles; do not submit to journals in regions where academic research is not very developed. Safe journals are those published by larger publishing groups or high-impact factor journals
(0) 讚! | 维尔娜菲茨杰拉德

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [EMBO REPORTS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*